{"title":"Caron如何使用GLP-1激动剂治疗SUD","authors":"Alison Knopf","doi":"10.1002/adaw.34596","DOIUrl":null,"url":null,"abstract":"<p>Caron Treatment Centers, a 70-year-old treatment program based in Wernersville, Pennsylvania, took an innovative step last year in offering GLP-1 agonists to patients. Last week Caron chief medical officer Adam D. Scioli, D.O., explained the rationale for the treatment adjunct.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 29","pages":"1-3"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"How Caron uses GLP-1 agonists in SUD treatment\",\"authors\":\"Alison Knopf\",\"doi\":\"10.1002/adaw.34596\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Caron Treatment Centers, a 70-year-old treatment program based in Wernersville, Pennsylvania, took an innovative step last year in offering GLP-1 agonists to patients. Last week Caron chief medical officer Adam D. Scioli, D.O., explained the rationale for the treatment adjunct.</p>\",\"PeriodicalId\":100073,\"journal\":{\"name\":\"Alcoholism & Drug Abuse Weekly\",\"volume\":\"37 29\",\"pages\":\"1-3\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-07-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alcoholism & Drug Abuse Weekly\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/adaw.34596\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alcoholism & Drug Abuse Weekly","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/adaw.34596","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
位于宾夕法尼亚州沃纳斯维尔的Caron治疗中心是一个有70年历史的治疗项目，去年在为患者提供GLP-1激动剂方面迈出了创新的一步。上周，Caron首席医疗官、医学博士亚当·d·肖利（Adam D. Scioli）解释了这种治疗辅助疗法的基本原理。
Caron Treatment Centers, a 70-year-old treatment program based in Wernersville, Pennsylvania, took an innovative step last year in offering GLP-1 agonists to patients. Last week Caron chief medical officer Adam D. Scioli, D.O., explained the rationale for the treatment adjunct.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
